Influence of an anti-diabetic foot ulcer formula and its component herbs on tissue and systemic glucose homeostasis

Journal of Ethnopharmacology

Volumn 109, Issue 1, 2007, Pages 10-20

  Chan, C M ^a   Chan, Y W ^a   Lau, C H ^a   Lau, T W ^a   Lau, K M ^a   Lam, F C ^a   Che, C T ^a   Leung, P C ^a   Fung, K P ^a   Lau, C B S ^a   Ho, Y Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese medicine; Diabetes; Foot ulcer; Glucose

Indexed keywords

ANTIDIABETIC AGENT; ASTRAGALUS MEMBRANACEUS EXTRACT; ATRACTYLODES MACROCEPHALA EXTRACT; FORMULA 1; HERBACEOUS AGENT; METFORMIN; PLANT EXTRACT; POLYGONUM MULTIFLORUM EXTRACT; REHMANNIA GLUTINOSA EXTRACT; SMILAX CHINA EXTRACT; STEPHANIA TETRANDRA EXTRACT; STREPTOZOCIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTRAGALUS MEMBRANACEUS; ATRACTYLODES MACROCEPHALA; CELL STRAIN 3T3; CHINESE HERB; CHINESE MEDICINE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DRUG ACTIVITY; DRUG FORMULATION; DRUG SCREENING; EXPERIMENTAL MODEL; FEMALE; GLUCONEOGENESIS; GLUCOSE ABSORPTION; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; INTESTINE BRUSH BORDER MEMBRANE; MEDICINAL PLANT; MEMBRANE VESICLE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; POLYGONUM MULTIFLORUM; RAT; REHMANNIA GLUTINOSA; SKIN FIBROBLAST; SMILAX CHINA; STEPHANIA TETRANDRA; STREPTOZOCIN DIABETES; TISSUE;

3T3 CELLS; ADIPOCYTES; ANIMALS; BLOOD GLUCOSE; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; DEOXYGLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FEMALE; FIBROBLASTS; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; MICE; MICROVILLI; PHYTOTHERAPY; PLANTS, MEDICINAL; RABBITS; RATS; RATS, WISTAR;

EID: 33751418681     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.06.003     Document Type: Article

References (27)

1. Barbera A., Fernandez-Alvarez J., Truc A., Gomis R., and Guinovart J.J. Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia. Diabetologia 40 (1997) 143-149
2. Creutzfeldt W., and Folsch U.R. Delaying Absorption as a Therapeutic Principle in Metabolic Diseases (1983), Georg Thieme Verlag, Stuttgart, Germany
3. Davies G.F., Khandelwal R.L., and Roesler W.J. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism. Biochimica Biophysica Acta 1451 (1999) 122-131
4. Freireich, E.J., Gehan, E.A., Rall, D.P., Schmidt, L.H., Skipper, H.E., 1966. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemotherapy Report. U.S. Department of Health, Education, and Welfare, Public Health Service, pp. 50, 219-244.
5. Gherzi R., Melioli G., De Luca M., D'Agostino A., Distefano G., Guastella M., D'Anna F., Franzi A.T., and Cancedda R. "HepG2/erythroid/brain" type glucose transporter (GLUT1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis. Journal of Cell Physiology 150 (1992) 463-474
6. Gokhale M.S., Shah D.H., Hakim Z., Santani D.D., and Goyal R.K. Effect of chronic treatment with amlodipine in non-insulin-dependent diabetic rats. Pharmacological Research 37 (1998) 455-459
7. Hemati N., Ross S.E., Erickson R.L., Groblewski G.E., and MacDougald O.A. Signaling pathways through which insulin regulates CCAAT/enhancer binding protein α (C/EBPα) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression. Journal of Biological Chemistry 272 (1997) 25913-25919
8. Hopfer U., Nelson K., Perrotto J., and Isselbacher K.J. Glucose transport in isolated brush border membrane from rat small intestine. Journal of Biological Chemistry 248 (1973) 25-32
9. Jarvill-Taylor K.J., Anderson R.A., and Graves D.J. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. Journal of the American College of Nutrition 20 (2001) 327-336
10. Kessler M., Acuto O., Storelli C., Murer H., Muller M., and SDenza G. A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of d-glucose and choline transport systems. Biochimica Biophysica Acta 506 (1978) 136-154
11. Kodama T., Iwase M., Nunoi K., Maki Y., Yoshinari M., and Fujishima M. A new diabetes model induced by neonatal alloxan treatment in rats. Diabetes Research and Clinical Practice 20 (1993) 183-189
12. Leahy J.L., Bonner-Weir S., and Weir G.C. Abnormal glucose regulation of insulin secretion in models of reduced β-cell mass. Diabetes 33 (1984) 667-673
13. Lochhead P.A., Coghlan M., Rice S.Q., and Sutherland C. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolpyruvate carboxykinase gene expression. Diabetes 50 (2001) 937-946
14. Lochhead P.A., Salt I.P., Walker K.S., Hardie D.G., and Sutherland C. 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49 (2000) 896-903
15. Moini H., Tirosh O., Park Y.C., Cho K.J., and Packer L. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Archives of Biochemistry and Biophysics 397 (2002) 384-391
16. Portha B., Levacher C., Picon L., and Rosselin G. Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes 23 (1974) 889-895
17. Schmitz J., Preiser H., Maestracci D., Ghosh B.K., Cerda J.J., and Crane R.K. Purification of the human intestinal brush border membrane. Biochimica Biophysica Acta 323 (1973) 98-112
18. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150 (1985) 76-85
19. State Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (2000), Chemical Industry Press, Beijing, China
20. Stefan Y., Orci L., Malaisse-Lagae F., Perrelet A., Patel Y., and Unger R.H. Quantitation of endocrine cell content in the pancreas of non-diabetic and diabetic humans. Diabetes 8 (1982) 694-700
21. Szalkowski D., White-Carrington S., Berger J., and Zhang B. Anti-diabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 136 (1995) 1474-1481
22. Waltner-Law M.E., Wang X.L., Law B.K., Hall R.K., Nawano M., and Granner D.K. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. Journal of Biological Chemistry 277 (2002) 34933-34940
23. Wang J.C., Stafford J.M., Scott D.K., Sutherland C., and Granner D.K. The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis. Journal of Biological Chemistry 275 (2000) 14717-14721
24. Weir G.C., Clore E.T., Zmachinski C.J., and Bonner-Weir S. Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes 30 (1981) 590-595
25. Wiese T.J., Lambeth D.O., and Ray P.D. The intracellular distribution and activities of phosphoenolpyruvate carboxykinase isozymes in various tissues of several mammals and birds. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 100 (1991) 297-302
26. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
27. Wong M.W., Leung P.C., and Wong W.C. Limb salvage in extensive diabetic foot ulceration-a preliminary clinical study using simple debridement and herbal drinks. Hong Kong Medical Journal 7 (2001) 403-407